Search for: "MAJOR PHARMACEUTICALS" Results 141 - 160 of 4,367
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Oct 2023, 11:42 pm by Rose Hughes
Particularly, understanding a mechanical invention generally does not require the complexity of data interpretation needed in the biotech and pharmaceutical field. [read post]
30 Sep 2023, 12:24 pm by Jonathan H. Adler
Court of Appeals for the Sixth Circuit stayed a preliminary injunction against a Tennessee law barring pharmaceutical and surgical gender-affirming care for minors diagnosed with gender dysphoria. [read post]
28 Sep 2023, 8:08 am by Andrews & Thornton
The County, State, utilities and landowners were given an astounding five years to prepare between major fires in Lahaina, but did nothing. [read post]
27 Sep 2023, 7:15 pm by Sabrina I. Pacifici
In all, according to our estimates, 75 percent of the benefits of striking down the MRT would go to just three sectors: tech, pharmaceuticals, and finance. [read post]
25 Sep 2023, 7:00 am by Amber Walsh
Within healthcare, Bain Capital targets companies in the provider services, hospital/major facilities, life sciences/pharmaceutical and non-reimbursement industries. [read post]
22 Sep 2023, 4:00 am by Jim Sedor
Louis Milione retired from the DEA a second time this summer amid reporting on potential conflicts caused by his prior consulting for the pharmaceutical industry. [read post]
21 Sep 2023, 10:34 am by Joe Mullin
For almost 30 years, some biotech and pharmaceutical companies actually applied for, and were granted, patents on naturally occuring human genes. [read post]
20 Sep 2023, 1:17 pm by Zak Gowen
  Delta Air Lines and United Airlines were ordered by a federal judge to face a consumer antitrust class action accusing major U.S. carriers of conspiring to drive up domestic airfares by reducing the number of available seats. [read post]
19 Sep 2023, 7:00 am by Geoff Cockrell
Founded in 2017, the firm seeks majority investments in businesses with between $3 million and $30 million of EBITDA. [read post]
19 Sep 2023, 6:30 am by Michelle Kendler-Kretsch
Yet there is no evidence in trade data that the contracted pharmaceutical products were delivered. [read post]
18 Sep 2023, 9:05 pm by Cookson Beecher
Industry experts predict that while it could be as far away as 100 years before the vast majority of the world’s meat will be made this way, they also say it probably won’t happen on any scale to speak of until the next 30 years. [read post]
18 Sep 2023, 7:11 pm by admin
The working groups are described as engaged in consensus evaluations, although past evaluations have been reached on simple majority vote of the working group. [read post]
15 Sep 2023, 10:26 am by Daniel J. Gilman
A statement on the settlement—issued by Khan and joined by Commissioners Rebecca Kelly Slaughter and Alvaro Bedoya—paints this as a win for the commission and consumers, and, not incidentally, “an advance in our pharmaceutical merger program. [read post]
14 Sep 2023, 4:00 am by AALL Spectrum
  Wouldn’t it be great if there were a worldwide, standard taxonomy—adopted by all major vendors, firms, and clients—to make legal data interoperable? [read post]
7 Sep 2023, 6:11 am by Mark Ashton
Early in my career, I was representing a numbers guy; very high up in the finance side of a major pharmaceutical house. [read post]
4 Sep 2023, 1:05 am by Rose Hughes
The majority of EU countries (including France, Italy and Spain) have granted the corresponding XADAGO SPCs, whilst Sweden has refused the Swedish SPC application (PMÄ 5610-18). [read post]
29 Aug 2023, 2:48 pm by lennyesq
However, the entire program is being contested in the courts by major pharmaceutical companies and industry groups, which could potentially delay or even halt implementation, with savings currently set to take effect in 2026. [read post]
26 Aug 2023, 9:16 am by Kluwer Patent blogger
Mobile communication and SEPs The first cases filed at the UPC include 12 infringement claims from Panasonic against various subsidiaries of Oppo and Xiaomi, in the first major dispute over mobile communications and SEPs. [read post]